Thomas Van Stavern is a seasoned professional in the pharmaceutical industry, currently serving as Vice President of Global Pharma Strategy and Lifecycle Leader for Cell Therapy at Genentech since 2025. They previously held various leadership roles at Genentech, including Executive Director of Global Product Strategy for TECENTRIQ and Senior Product Manager for Rituxan. Thomas began their career at Strategic Decisions Group as a Consultant and also completed a Product Management internship at Amazon.com. They earned an MBA from Stanford University Graduate School of Business and a BS from the University of California, Berkeley.
Location
Burlingame, United States
Links
This person is not in any teams
This person is not in any offices